Is disease-specific health-related quality of life measurement a necessary evil when assessing clinical outcomes in inflammatory bowel disease?
Irvine
E J
EJ
Div Gastroenterology, McMaster University, Hamilton, Ontario, Canada. irvinej@mcmaster.ca
D006305:Health Status Indicators; D006801:Humans; D015212:Inflammatory Bowel Diseases; D011788:Quality of Life; D016896:Treatment Outcome